Preliminary evidence for association between schizophrenia and polymorphisms in the regulatory Regions of the ADRA2A, DRD3 and SNAP-25 Genes

• Published in: Psychiatry research 2013-01, Vol.205 (1), p.7-12
• Main Authors: Lochman, Jan, Balcar, Vladimir J, Šťastný, František, Šerý, Omar
• Format: Article
• Language: English
• Subjects: Adrenergic receptor; Adult; Adult and adolescent clinical studies; Association; Biological and medical sciences; Case-Control Studies; Dopamine receptor; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Humans; Likelihood Functions; Male; Medical sciences; Middle Aged; Polymorphism, Single Nucleotide; Psychiatry; Psychology. Psychoanalysis. Psychiatry; Psychopathology. Psychiatry; Psychoses; Receptors, Adrenergic, alpha-2 - genetics; Receptors, Dopamine D3 - genetics; Schizophrenia; Schizophrenia - genetics; Synaptosomal-Associated Protein 25 - genetics
• ISSN: 0165-1781; 1872-7123
• DOI: 10.1016/j.psychres.2012.08.003

Abstract The results of linkage and candidate gene association studies have led to a range of hypotheses about the pathogenesis of schizophrenia. We limited our study to polymorphisms in candidate genes involved in dopaminergic and noradrenergic systems, and in the 25 KDa synaptosomal-associated protein (SNAP-25) gene that is related to neurotransmitter exocytosis. Eight single nucleotide polymorphisms (SNPs) in regulating or coding regions of genes for the alpha-2A adrenergic receptor (ADRA2A), dopamine receptors D1 and D3 (DRD1 and DRD3), dopamine β-hydroxylase (DBH) and SNAP-25 were genotyped in male patients with schizophrenia ( n =192) and in healthy controls ( n =213). These polymorphisms were previously associated with schizophrenia. The allelic association between schizophrenia and ADRA2A rs1800544 polymorphism, SNAP-25 rs1503112 polymorphism, and DRD3 rs6280 polymorphism was found in our study. However, only observations for rs1503112 survived correction for multiple testing. Association was also evaluated by considering the polymorphisms as interactions; in this case, a likelihood ratio test (LRT) revealed evidence for association with schizophrenia in four polymorphism combinations: two DRD3 * SNAP-25 combinations (rs6280*rs3746544 and rs6280*rs3746544, P =0.02), one ADRA2A * SNAP25 combination (rs1800544*rs3746544) and one ADRA2A * DBH combination (rs1800544*rs2519152). Our results are in agreement with the previously proposed role of DNA polymorphisms involved in dopaminergic, noradrenergic and synaptic functions in the pathogenesis of schizophrenia. Further relevant studies including larger sample size and more markers are needed to confirm our results.